Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Study of JS001 in Patients With Advanced Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03167853
Recruitment Status : Completed
First Posted : May 30, 2017
Last Update Posted : June 21, 2019
Shanghai Junshi Biosciencee Co.,Ltd
Information provided by (Responsible Party):
Shen Lin, Peking University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 11, 2018
Actual Study Completion Date : May 11, 2019